Capstone Investment Advisors
ABVX

Capstone Investment Advisors’s Abivax ABVX Stock Holding History

Capstone Investment Advisors’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-62,966
Closed -$900K – 2036
2024
Q1 		$900K Buy
62,966
+5,199
+9% +$67K ﹤0.01% 1212
2023
Q4 		$618K Buy
+57,767
New +$589K ﹤0.01% 1237

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Capstone Investment Advisors's ABVX Position: Q2 2024 in Review

Capstone Investment Advisors sold out of Abivax (ABVX) in Q2 2024, closing a stake of 62,966 shares — an estimated $900K sold.

Capstone Investment Advisors first reported a position in ABVX in Q4 2023 and held it in 2 quarters. The position peaked at $900K in Q1 2024. 38 funds tracked by Wall St. Rank hold ABVX as of Q2 2024.

  • Capstone Investment Advisors reported no remaining Abivax position as of Q2 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 62,966 Abivax shares in Q2 2024, an estimated $900K.
  • Capstone Investment Advisors first reported a position in Abivax in Q4 2023 and held it in 2 quarters.
  • Capstone Investment Advisors's Abivax position peaked at $900K in Q1 2024.
  • 38 funds tracked by Wall St. Rank held Abivax as of Q2 2024.

Based on Capstone Investment Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.